Showing results (1601-1610 of 6,713) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|June 26, 2015
Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trialsShunchao Yan, Kai Li, Xin Jiao, et al.
Oncotargets and Therapy|June 26, 2015
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinomaLi Jiang, Liang Wang, Peng-Fei Li, et al.
Oncotargets and Therapy|June 26, 2015
Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trialsXiaoping Liu, Colin K He, Xiangyu Meng, et al.
Oncotargets and Therapy|June 26, 2015
Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agentsXin He, Yumei Hao, Wei Long, et al.
Oncotargets and Therapy|August 4, 2016
Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literatureYou-Cai Zhu, Chun-Wei Xu, Xiao-Qian Ye, et al.
Oncotargets and Therapy|August 4, 2016
MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12Tian Liang, Liru Li, Yan Cheng, et al.
Oncotargets and Therapy|August 4, 2016
Association between CD14 SNP -159 C/T and gastric cancer: an independent case-control study and an updated meta-analysisAi-Min Gong, Xin-Yuan Li, Yi-Qiang Xie, et al.
Oncotargets and Therapy|August 25, 2022
RPL38 Regulates the Proliferation and Apoptosis of Gastric Cancer via miR-374b-5p/VEGF Signal Pathway [Retraction]
Oncotargets and Therapy|September 16, 2021
microRNA-493 Inhibits Tongue Squamous Cell Carcinoma Oncogenicity via Directly Targeting HMGA2 [Retraction]
Oncotargets and Therapy|September 16, 2021
Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction]
Pageof 672